Nosocomial Candida krusei fungemia in cancer patients: Report of 10 cases and review

Journal of Chemotherapy

Volumn 11, Issue 2, 1999, Pages 131-136

  Krcmery Jr , V ^a,b,c   Spanik, S ^a,b   Kunova, A ^a   Trupl, J ^a,b   Grausova, S ^b   Krupova, I ^a,b   Mateicka, F ^b   Pichnova, E ^b   Grey, E ^b   Sabo, A ^b  

^a St Elisabeth Cancer Institute   (Slovakia)

^b TRNAVA UNIVERSITY   (Slovakia)

^c Heydukova 10   (Slovakia)

Author keywords

Amphotericin B; Candida albicans; Candida krusei; Fluconazole; Fungemia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; CEFOTAXIME; CEFTAZIDIME; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PIPERACILLIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD VESSEL CATHETERIZATION; CANCER; CANDIDA KRUSEI; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; FEBRILE NEUTROPENIA; FUNGEMIA; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; ORAL DRUG ADMINISTRATION; RISK FACTOR; TREATMENT OUTCOME;

EID: 0032947461     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.2.131     Document Type: Article

References (38)

1. 1 Wingard J. Importance of Candida spp. other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995; 20: 115-125.
2. 2 Wingard J. Increase in C. krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325, 19: 1274-1277.
3. 3 Kunova A, Trupl J, Krcmery V Jr. Candida glabrata and C. krusei in 1989-1993 among fungal organisms from a single National Cancer Institute: no association with the use of fluconazol. Chemotherapy 1995; 41, 1: 133-139.
4. 4 Iwou PC, Kelly D, Reed E, Hinricks S. Invasive infection due to Candida krusei not treated with fluconazol. Clin Infect Dis 1995; 20: 342-397.
5. 5 Papas PG, Rex MJ, Hamill RA, et al. Current trends in nosocomial candidaemia: Results of large multicenter study. Abstract 35-th IDzSA Annual meeting, 13-16 Sept. 1997 San Francisco, Abstract no. 13.
6. 6 Viscoli C, and the ICFCG EORTC cooperative group. Fungemia in cancer patients in Europe. Abstracts, 3-th ECCMID, Vienna 1-3.4. 1995, Abstract no. 133
7. 7 Krcmery V Jr, Oravcova E, Spanik S, et al. Breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy. J Antimicrob Chemother 1998; 41: 373-380.
8. 8 Clancy CJ. Correlation between in vitro susceptibility testing of Candida determined E test with microbiologic response to Amphotericin B. 35th IDSA Annual meeting, 13-16 September 1997, San Francisco, Abstract n. 14.
9. 9 Babincak TJ, Chan J, Tompkin NH. Clinical outcome of Candida blood stream infection based upon susceptibility testing. 35th IDSA Annual meeting. 13-16 Sept. 1997 San Francisco, Abstract no. 141.
10. 10 Lee J, Peterson L, Noskin G. Correlation of antifungal susceptibility testing with clinical outcome. 35th IDSA annual meeting, 13-16. Sept. 1997 San Francisco, Abstract no. 145.
11. 11 Doongnah L, Dalaponha R, Pekers D, Peoples J, McNeil J, Frederich WR. Fungemia in intensive care patients. 35th IDSA Annual meeting, 13-16 Sept. 1997, San Francisco, Abstract no. 149.
12. 12 Jernigan JA, Nolte FS, Akkerman V, Andros A. The changing spectrum of candidaemia at a University Hospital. 35th IDSA Annual meeting, 13-16 Sept. 1997, San Francisco, Abstract no. 661.
13. 13 White M. Epidemiology of invasive candidiasis. Int J Infect Dis 1997; 51,1: 7-10.
14. 14 Lecciones J, Lee LW, Navano EE, et al. Vascular catheter-associated fungemia in patients with cancer. Clin Infect Dis 1992; 14: 875-883.
15. 15 Nguyen HM, Peacock JE, Tanner DC, et al. Therapeutic approach in patients with candidaemia. Arch Int Med 1995; 155, 11: 2429-2438.
16. 16 Kramer DG, Bastic GP, Perri HB, Band JD. Fungemia at a community hospital. 34th IDSA 13-16. Sept. 1997 San Francisco, Abstract.
17. 17 Voss A, Noble LLMJL, Lunel VFM, Foudraino NA, Meis MGFJ. Candidaemia in intensive care unit patients. Infection 1997; 25, 1: 8-15.
18. 18 Al Soub H, Estinoso W. Hospital acquired candidaemia. J Hosp Infect 1997; 35, 3: 141-147.
19. 19 Stanuos KJ, Rowley AH. Candidaemia in pediatric population. Clin Infect Dis 1995; 20, 6: 571-575.
20. 20 Roilides E, Kadiltsoglou I, Zahides D, Bibaski E. Invasive candidiosis in pediatric patients. Clin Microbial Infect 1997; 3, 4: 192-195.
21. 21 Englund K, Noskin G, Kruszynski J, Peterson L. Yeasts on the rise. 34th IDSA Annual meeting, New Orleans, Abstract no. 341.
22. 22 Goldman M, Pottage J, Weaner DC. Candida krusei fungemia. Medicine 1993; 2, 3: 143-147.
23. 23 Quillen DPM, Zingmann BS, Meunier F, Levitz SM. Invasive infection due to Candida krusei that include ten cases of endophthalmitis. Clin Infect Dis 1992; 14: 472-478.
24. 24 Berger C, Fuzi R, Gratwohl A, Tichelli A, Hofliger B, Specks B. Epidemie mit Candida krusei an einer Hamatologisen Abteitung. Schweiz Med Wochenschrift 1993; 118: 495-503.
25. 25 Horn R, Wong B, Kichu TE, Armstrong D. Fungemia in a cancer hospital. Rev Infect Dis 1985; 7: 646-655.
26. 26 Mertz WG, Karp JE, Schron D, Saral R. Increased incidence of fungemia caused by C. krusei. J Clin Microbiol 1986; 24: 581-584.
27. 27 Gordon RA, Simmons BP, Appelbaum PC, Aber RC. Intraabdominal abscess fungemia caused by Candida krusei. Arch Intern Med 1980; 140: 1239-1240.
28. 28 Rubenstein E, Noriega ER, Simberkoff MS, Holzman R, Rahal JJ. Fungal emdocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) 1975; 54: 331-344.
29. 29 Nguyen VQ, Penn RL. Candida krusei infectious arthritis - a rare complication of neutropenia. Am J Med 1987; 83: 963-965.
30. 30 Carcassi A, Saletti M, Boschi S. Artrite acuta da Candida - isolamento di Candida krusei in un eroinomane. Minerva Med 1982; 73: 2905-2909.
31. 31 Thomalla JV, Steidle CP, Leapman SB, Filo RS. Ureteral obstruction of a renal allograft secondary to Candida krusei. Transplant Proc 1988; 20: 551-554.
32. 32 Casasnavas R, Caillot D, Solary, E et al. Prophylactic fluconazole and Candida krusei infection. N Engl J Med 1992; 326: 891-892.
33. 33 Case CP, Mackowan AP, Brown NM, Reeves DS, Whitehead P, Felmingham D. Prophylactic oral fluconazole and Candida fungemia. Lancet 1991; 337: 790.
34. 34 Persons DA, Langhlin M, Tanner P, Perfect J, Gocheman JP, Hathorn JN. Fluconazole and C. krusei fungemia. N Engl J Med 1991; 325: 1315.
35. 35 Bignardi GE, Savage MA, Coher R, Daris SG. Fluconazole and C. krusei infections. J Hosp Infect 1991; 18: 326-327.
36. 36 Diggs LH, Esttenasy GM, Sutherland JC, Wierniha PH. Fungal infections of muscle in acute leukemia. Cancer 1976; 38: 1771-1772.
37. 37 McIlroy MA. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia and typhlitis. J Infect Dis 1991; 163: 420-421.
38. 38 Abi Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida spp. Clin Infect Dis 1998; 20, 2: 133-141.